- ISIN
- US03837C1062
- CUSIP
- 03837C106
- Sector
- Healthcare
- Industry
- Medical Devices
- IPO Date
- Jan 1, 1987
Highlights
- Market Cap
- $172.65M
- Enterprise Value
- $146.33M
- EPS (TTM)
- -$0.33
- Total Revenue (TTM)
- $55.83M
- Gross Profit (TTM)
- $21.29M
- EBITDA (TTM)
- -$3.18M
- Year Range
- $1.70 - $5.08
- Target Price
- $6.00
- ROA (TTM)
- -14.55%
- ROE (TTM)
- -71.45%
- Avg. Volume (1M)
- 60K
- Avg. Volume Value (1M)
- $250.43K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
APYX Performance Chart
Apyx Medical Corporation (APYX) is up 17.1% since the beginning of the year. At $4 per share, APYX is trading 19.3% below its 52-week high of $5. Investors who bought $1,000 worth of APYX shares 5 years ago would now be looking at an investment worth $456.
Loading charts...
Compare this symbol against anything
Returns By Period
Apyx Medical Corporation (APYX) has returned 17.14% so far this year and 134.29% over the past 12 months.
Apyx Medical Corporation
- 1D
- -0.49%
- 1M
- -4.65%
- 6M
- 1.99%
- YTD
- 17.14%
- 1Y
- 134.29%
- 3Y*
- -9.49%
- 5Y*
- -14.55%
- 10Y*
- —
- ALL TIME*
- -8.39%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
APYX Monthly Returns History
Based on dividend-adjusted daily data since Jan 2, 2019, APYX's average daily return is +0.14%, while the average monthly return is +2.20%. At this rate, an investment would double in approximately 2.7 years.
Historically, 49% of months were positive and 51% were negative. The best month was May 2023 with a return of +86.2%, while the worst month was Nov 2022 at -64.8%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.
On a daily basis, APYX closed higher 47% of trading days. The best single day was May 26, 2022 with a return of +51.9%, while the worst single day was Nov 10, 2022 at -60.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 14.86% | -18.66% | 12.84% | -9.76% | 19.97% | 12.39% | -8.69% | 17.14% | |||||
| 2025 | -8.86% | 0.69% | -5.52% | -24.09% | 50.00% | 44.23% | -15.11% | 4.19% | 7.54% | 41.59% | 32.34% | -12.72% | 121.52% |
| 2024 | -14.50% | -6.25% | -35.24% | 5.15% | 15.38% | -18.79% | 1.49% | -2.21% | -6.77% | -5.65% | 37.61% | -1.86% | -39.69% |
| 2023 | 24.79% | 11.30% | -11.38% | 18.06% | 86.18% | -20.54% | 11.13% | -16.64% | -31.33% | -28.44% | 3.06% | 11.02% | 11.97% |
| 2022 | -10.30% | -12.00% | -35.47% | -42.27% | 61.01% | -3.46% | 61.43% | -39.43% | -21.64% | 11.36% | -64.80% | 32.95% | -81.75% |
| 2021 | 29.03% | 12.49% | -7.56% | 4.87% | -3.36% | 5.31% | -12.71% | 31.22% | 17.27% | 3.25% | -6.08% | -4.54% | 78.06% |
Benchmark Metrics
Apyx Medical Corporation has an annualized alpha of 15.46%, beta of 1.29, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since January 02, 2019.
- This stock participated in 168.01% of S&P 500 Index downside but only 82.33% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 15.46%
- Beta
- 1.29
- R²
- 0.07
- Upside Capture
- 82.33%
- Downside Capture
- 168.01%
Return for Risk
Risk / Return Rank
APYX ranks 85 for risk / return — above 85% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Apyx Medical Corporation (APYX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| APYX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.02 | ||
| Sortino ratioReturn per unit of downside risk | +0.44 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.25 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | 3.15 | 2.00 | +1.15 |
| Martin ratioReturn relative to average drawdown | 8.56 | 8.49 | +0.07 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Apyx Medical Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Apyx Medical Corporation was 94.99%, occurring on Apr 8, 2025. The portfolio has not yet recovered.
The current Apyx Medical Corporation drawdown is 76.44%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-94.99%Apr 2025 | 3y 4mo | — | 4y 8moNov 2021 - now | 2025 selloff2025 |
-67.20%May 2020 | 1y 3mo | 8mo 12d | 1y 11moJan 2019 - Jan 2021 | — |
-25.57%Aug 2021 | 4mo 23d | 1mo 23d | 6mo 16dMar 2021 - Sep 2021 | — |
-18.34%Jan 2019 | 1d | 7d | 8dJan 2019 - Jan 2019 | — |
-17.23%Feb 2021 | 7d | 23d | 1moJan 2021 - Feb 2021 | — |
Drawdown Indicators
| APYX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.99% | -56.78% | -38.21% |
Max Drawdown (1Y)Largest decline over 1 year | -36.59% | -9.10% | -27.49% |
Max Drawdown (3Y)Largest decline over 3 years | -83.52% | -18.90% | -64.62% |
Max Drawdown (5Y)Largest decline over 5 years | -94.99% | -25.43% | -69.56% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -76.44% | -1.58% | -74.86% |
Average DrawdownAverage peak-to-trough decline | -57.33% | -10.70% | -46.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.46% | 2.14% | +11.32% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Apyx Medical Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Apyx Medical Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for APYX relative to other companies in the Medical Devices industry. Currently, APYX has a P/S ratio of 2.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with APYX
Add Apyx Medical Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with APYX